World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Biology and Biochemistry 47 18567 17031 7586 6762 111 13007

Dung Fang Lee publications per year

The chart shows the history of publications by Dung Fang Lee between 1998 and 2021, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Dung Fang Lee published across 24 years, from 1998 to 2021, averaging 4 papers a year. Output peaked at 12 publications in 2018. 17 of the 95 publications appeared in the last two years.

No. of publications
5 10
Bar chart. Horizontal axis: year, 1998 to 2021. Vertical axis: number of publications, 0 to 12. Peak 12 publications in 2018. 1998: 1 publication 1999: 0 publications 2000: 1 publication 2001: 0 publications 2002: 0 publications 2003: 0 publications 2004: 4 publications 2005: 3 publications 2006: 1 publication 2007: 5 publications 2008: 5 publications 2009: 5 publications 2010: 4 publications 2011: 8 publications 2012: 6 publications 2013: 1 publication 2014: 3 publications 2015: 7 publications 2016: 3 publications 2017: 6 publications 2018: 12 publications 2019: 3 publications 2020: 6 publications 2021: 11 publications
1998 2021

95 publications in total across all disciplines

View publications per year as a table
Dung Fang Lee: publications per year, 1998 to 2021
Year Publications
1998 1
1999 0
2000 1
2001 0
2002 0
2003 0
2004 4
2005 3
2006 1
2007 5
2008 5
2009 5
2010 4
2011 8
2012 6
2013 1
2014 3
2015 7
2016 3
2017 6
2018 12
2019 3
2020 6
2021 11
Total 95
Download as CSV

Dung Fang Lee publications per year - data summary

  • Dung Fang Lee, a Biology and Biochemistry scholar from The University of Texas Health Science Center at Houston, has 95 publications recorded across 24 years, from 1998 to 2021.
  • The oldest publication on record dates to 1998 and the most recent to 2021.
  • The most productive year is 2018, with 12 publications.
  • The least productive years with any output are 1998, 2000, 2006 and 2013, with 1 publication each.
  • 4 of the 24 years in the span carry no publications at all (1999, 2001, 2002 and 2003).
  • The rate of publication averages 4.0 papers per year over the whole span, or 4.8 per year counting only the 20 years with at least one publication.
  • The last 5 years on the chart (2017-2021) hold 38 publications, 40% of the career total.
  • Split into equal eras - 1998-2005: 9 publications (1.1 per year); 2006-2013: 35 publications (4.4 per year); 2014-2021: 51 publications (6.4 per year).
  • Comparing the opening and closing eras, the overall trend of publication is rising.

Dung Fang Lee publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Dung Fang Lee sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 100 bars. Horizontal axis: publications, 47–56 to 1,028+. Vertical axis: number of scientists, 0 to 980. Most scientists, 980, have 127–136 publications. The last bar groups every scientist with 1,028 publications or more. The highlighted bar, 107–116 publications, is where this scientist sits. 47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientist 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientist 1,028+ publications: 100 scientists
47–56 publications 1,028+

This scientist: 111 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

View publications distribution as a table
Number of Biology and Biochemistry scientists by publication count, Research.com 2026 ranking edition. Based on 19,587 ranked scientists.
Publications Scientists This scientist
47–56 8
57–66 35
67–76 106
77–86 231
87–96 413
97–106 546
107–116 704 111
117–126 848
127–136 980
137–146 942
147–156 969
157–166 949
167–176 951
177–186 915
187–196 787
197–206 840
207–216 733
217–226 708
227–236 651
237–246 605
247–256 510
257–266 524
267–276 434
277–286 417
287–296 350
297–306 363
307–316 315
317–326 296
327–336 261
337–346 240
347–356 219
357–366 196
367–376 154
377–386 161
387–396 155
397–406 145
407–416 124
417–426 112
427–436 132
437–446 116
447–456 99
457–466 81
467–476 91
477–486 80
487–496 80
497–506 59
507–516 36
517–526 46
527–536 54
537–546 44
547–556 43
557–566 43
567–576 42
577–586 25
587–596 34
597–606 23
607–616 33
617–626 31
627–636 27
637–646 25
647–656 28
657–666 34
667–676 18
677–686 16
687–696 10
697–706 12
707–716 21
717–726 12
727–736 12
737–746 10
747–756 7
757–766 13
767–776 15
777–786 13
787–796 9
797–806 9
807–816 7
817–826 4
827–836 9
837–846 7
847–856 3
857–866 5
867–876 5
877–886 11
887–896 3
897–906 4
907–916 7
917–926 5
927–936 6
937–946 6
947–956 3
957–966 7
967–976 2
977–986 2
987–996 1
997–1,006 5
1,007–1,016 2
1,017–1,026 2
1,027 1
1,028+ 100
Download as CSV

Dung Fang Lee publication distribution in Biology and Biochemistry in 2026 - data summary

  • The chart plots the publication count of all 19,587 Biology and Biochemistry scientists ranked by Research.com in 2026, grouped into 100 ranges running from 47–56 to 1,028+ publications.
  • Dung Fang Lee, a Biology and Biochemistry scholar from The University of Texas Health Science Center at Houston, records 111 publications - the 9th percentile of the discipline.
  • 9% of ranked Biology and Biochemistry scientists score the same or lower than Dung Fang Lee, and about 91% score higher.
  • The median of the discipline falls in the 197–206 publications range, and Dung Fang Lee ranks below the median.
  • The most crowded range is 127–136 publications, holding 980 scientists (5% of the field).
  • 77% of the field sits in the lowest quarter of the value range (up to 287–296 publications), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 1,028 publications or more, 100 scientists in all (<1% of the field).

Dung Fang Lee D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Dung Fang Lee sits on this spectrum.

No. of scientists
250 500 750 1,000 1,250
Bar chart with 65 bars. Horizontal axis: D-Index, 40–41 to 167+. Vertical axis: number of scientists, 0 to 1,253. Most scientists, 1,253, have 58–59 D-Index. The last bar groups every scientist with 167 D-Index or more. The highlighted bar, 46–47 D-Index, is where this scientist sits. 40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40–41 D-Index 167+

This scientist: 47 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

View D-Index distribution as a table
Number of Biology and Biochemistry scientists by D-index, Research.com 2026 ranking edition. Based on 19,587 ranked scientists.
D-Index Scientists This scientist
40–41 80
42–43 183
44–45 316
46–47 504 47
48–49 718
50–51 899
52–53 1,025
54–55 1,149
56–57 1,235
58–59 1,253
60–61 1,162
62–63 1,130
64–65 1,031
66–67 897
68–69 814
70–71 714
72–73 709
74–75 596
76–77 512
78–79 473
80–81 412
82–83 373
84–85 358
86–87 285
88–89 273
90–91 227
92–93 208
94–95 193
96–97 153
98–99 157
100–101 148
102–103 120
104–105 113
106–107 100
108–109 86
110–111 67
112–113 71
114–115 73
116–117 64
118–119 53
120–121 60
122–123 54
124–125 43
126–127 38
128–129 49
130–131 26
132–133 18
134–135 23
136–137 32
138–139 32
140–141 27
142–143 19
144–145 22
146–147 12
148–149 16
150–151 14
152–153 10
154–155 13
156–157 10
158–159 7
160–161 9
162–163 13
164–165 4
166 4
167+ 98
Download as CSV

Dung Fang Lee D-index placement in Biology and Biochemistry in 2026 - data summary

  • The chart plots the discipline H-index (D-index) of all 19,587 Biology and Biochemistry scientists ranked by Research.com in 2026, grouped into 65 ranges running from 40–41 to 167+ D-Index.
  • Dung Fang Lee, a Biology and Biochemistry scholar from The University of Texas Health Science Center at Houston, records 47 D-Index - the 6th percentile of the discipline.
  • 6% of ranked Biology and Biochemistry scientists score the same or lower than Dung Fang Lee, and about 94% score higher.
  • The median of the discipline falls in the 64–65 D-Index range, and Dung Fang Lee ranks below the median.
  • The most crowded range is 58–59 D-Index, holding 1,253 scientists (6% of the field).
  • 71% of the field sits in the lowest quarter of the value range (up to 72–73 D-Index), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 167 D-Index or more, 98 scientists in all (<1% of the field).

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Transcription factor

His primary areas of study are Signal transduction, Cancer research, Cell biology, Downregulation and upregulation and Cell growth. In general Signal transduction, his work in PI3K/AKT/mTOR pathway and ErbB is often linked to ROR1 linking many areas of study. His Cancer research research is multidisciplinary, relying on both I-Kappa-B Kinase, Akt/PKB signaling pathway, CHUK, Hypertelorism and PTPN11.

His Cell biology research incorporates themes from Ubiquitin, Ubiquitin ligase, Carcinogenesis, Reprogramming and IκB kinase. His work focuses on many connections between Downregulation and upregulation and other disciplines, such as MAPK/ERK pathway, that overlap with his field of interest in Catenin, Oncogene, Beta-catenin and Transplantation. His studies deal with areas such as Receptor tyrosine kinase and Phosphorylation as well as Catenin.

His most cited work include:

  • IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a (750 citations)
  • Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome (584 citations)
  • IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway (511 citations)

What are the main themes of his work throughout his whole career to date?

Dung Fang Lee mainly focuses on Cancer research, Cell biology, Induced pluripotent stem cell, Signal transduction and Carcinogenesis. His biological study spans a wide range of topics, including Cancer, Metastasis, Cell growth, Downregulation and upregulation and Phosphorylation. His Downregulation and upregulation research is multidisciplinary, incorporating elements of Oncogene, Mdm2, Transplantation and MAPK/ERK pathway.

The concepts of his Cell biology study are interwoven with issues in Embryonic stem cell, Ubiquitin, IκB kinase and Homeobox protein NANOG. His work carried out in the field of Signal transduction brings together such families of science as Molecular biology, Kinase, Beta-Transducin Repeat-Containing Proteins and Transactivation. Dung Fang Lee interconnects Germline mutation, Wnt signaling pathway, Angiogenesis and GSK-3 in the investigation of issues within Carcinogenesis.

He most often published in these fields:

  • Cancer research (72.97%)
  • Cell biology (46.85%)
  • Induced pluripotent stem cell (28.83%)

What were the highlights of his more recent work (between 2015-2021)?

  • Cancer research (72.97%)
  • Induced pluripotent stem cell (28.83%)
  • Cell biology (46.85%)

In recent papers he was focusing on the following fields of study:

Cancer research, Induced pluripotent stem cell, Cell biology, Cancer and Osteosarcoma are his primary areas of study. His Cancer research study integrates concerns from other disciplines, such as Germline mutation, Carcinogenesis, Transcriptome, Metastasis and Notch signaling pathway. The Induced pluripotent stem cell study combines topics in areas such as Angiogenesis, Disease, Pathogenesis and Li–Fraumeni syndrome.

His Cell biology study combines topics from a wide range of disciplines, such as Mutation, Embryonic stem cell, Oxidative phosphorylation and Germ layer. His Cancer research includes elements of Genome editing, Reprogramming, Cellular differentiation and Bioinformatics. In his research, Mitochondrion and Downregulation and upregulation is intimately related to Pediatric cancer, which falls under the overarching field of Mesenchymal stem cell.

Between 2015 and 2021, his most popular works were:

  • Osteosarcoma: Molecular Pathogenesis and iPSC Modeling (57 citations)
  • MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1. (47 citations)
  • AKT1 inhibits epithelial-to-mesenchymal transition in breast cancer through phosphorylation-dependent Twist1 degradation (45 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Transcription factor

Dung Fang Lee spends much of his time researching Induced pluripotent stem cell, Cancer research, Bioinformatics, Stem cell and Genome editing. Dung Fang Lee combines subjects such as Cancer, Cancer Etiology, Pathogenesis and Human disease, Disease with his study of Induced pluripotent stem cell. His work on Osteosarcoma as part of general Cancer research study is frequently linked to AKT2, therefore connecting diverse disciplines of science.

Dung Fang Lee interconnects Intrahepatic Cholangiocarcinoma, Genomic profiling, Advanced stage, Cause of death and Liver cancer in the investigation of issues within Bioinformatics. His Stem cell research is multidisciplinary, incorporating perspectives in DNA-binding protein, Transcription factor, Zinc finger, Chromatin and Molecular biology. Dung Fang Lee focuses mostly in the field of Genome editing, narrowing it down to topics relating to Cellular differentiation and, in certain cases, Cell, Retinoblastoma, Cell biology, Cas9 and Germline.

Best Publications

  • IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a

    Mickey C.T. Hu;Dung Fang Lee;Weiya Xia;Leonard S. Golfman

  • IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway

    Dung Fang Lee;Hsu Ping Kuo;Hsu Ping Kuo;Chun Te Chen;Chun Te Chen;Jung Mao Hsu;Jung Mao Hsu

  • ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

    Jer Yen Yang;Cong S. Zong;Weiya Xia;Hirohito Yamaguchi

  • Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome

    Xonia Carvajal-Vergara;Ana Sevilla;Sunita L. Dsouza;Yen Sin Ang

  • Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin

    Qingqing Ding;Weiya Xia;Jaw Ching Liu;Jer Yen Yang;Jer Yen Yang

  • Wdr5 Mediates Self-Renewal and Reprogramming via the Embryonic Stem Cell Core Transcriptional Network

    Yen Sin Ang;Su Yi Tsai;Dung Fang Lee;Jonathan Monk

  • KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma

    Jianhua Ling;Ya'an Kang;Ruiying Zhao;Qianghua Xia

  • Degradation of Mcl-1 by β-TrCP Mediates Glycogen Synthase Kinase 3-Induced Tumor Suppression and Chemosensitization

    Qingqing Ding;Xianghuo He;Jung Mao Hsu;Jung Mao Hsu;Weiya Xia

  • KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ

    Dung Fang Lee;Hsu Ping Kuo;Hsu Ping Kuo;Mo Liu;Mo Liu;Chao Kai Chou;Chao Kai Chou

  • The Crosstalk of mTOR/S6K1 and Hedgehog Pathways

    Yan Wang;Qingqing Ding;Chia Jui Yen;Weiya Xia

  • Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2

    Shao Chun Wang;Huang Chun Lien;Weiya Xia;I. Fen Chen

  • FOXO1 is an essential regulator of pluripotency in human embryonic stem cells

    Xin Zhang;Safak Yalcin;Dung Fang Lee;Tsung Yin J. Yeh

  • Coordination of m 6 A mRNA Methylation and Gene Transcription by ZFP217 Regulates Pluripotency and Reprogramming

    Francesca Aguilo;Fan Zhang;Ana Sancho;Miguel Fidalgo

  • Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor.

    Dipak K. Giri;Mohamed Ali-Seyed;Long Yuan Li;Dung Fang Lee

  • Myeloid Cell Leukemia-1 Inversely Correlates with Glycogen Synthase Kinase-3β Activity and Associates with Poor Prognosis in Human Breast Cancer

    Qingqing Ding;Xianghuo He;Weiya Xia;Jung Mao Hsu

  • Phosphorylation/Cytoplasmic Localization of p21Cip1/WAF1 Is Associated with HER2/neu Overexpression and Provides a Novel Combination Predictor for Poor Prognosis in Breast Cancer Patients

    Weiya Xia;Jin Shing Chen;Jin Shing Chen;Xian Zhou;Pei Rong Sun

  • Modeling Familial Cancer with Induced Pluripotent Stem Cells

    Dung Fang Lee;Jie Su;Huen Suk Kim;Betty Chang

  • Down-regulation of Myeloid Cell Leukemia-1 through Inhibiting Erk/Pin 1 Pathway by Sorafenib Facilitates Chemosensitization in Breast Cancer

    Qingqing Ding;Longfei Huo;Jer Yen Yang;Jer Yen Yang;Weiya Xia

  • Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1.

    Chao Li;Junping Ao;Junjiang Fu;Dung-Fang Lee

  • All roads lead to mTOR: integrating inflammation and tumor angiogenesis.

    Dung Fang Lee;Mien Chie Hung

Frequent Co-Authors

Mien Chie Hung
Mien Chie Hung China Medical University
Ihor R. Lemischka
Ihor R. Lemischka Icahn School of Medicine at Mount Sinai
Weiya Xia
Weiya Xia The University of Texas MD Anderson Cancer Center
Yongkun Wei
Yongkun Wei The University of Texas MD Anderson Cancer Center
Chang Hai Tsai
Chang Hai Tsai Asian University
Fuu Jen Tsai
Fuu Jen Tsai China Medical University
Gabriel N. Hortobagyi
Gabriel N. Hortobagyi The University of Texas MD Anderson Cancer Center
Aysegul A. Sahin
Aysegul A. Sahin The University of Texas MD Anderson Cancer Center
Bruce D. Gelb
Bruce D. Gelb Icahn School of Medicine at Mount Sinai
Natalia Ivanova
Natalia Ivanova Lawrence Berkeley National Laboratory

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Dung Fang Lee

Trending Scientists

Recently Published Articles